Bio Rad Laboratories Stock Today

BIO Stock  USD 349.56  9.04  2.65%   

Performance

6 of 100

 
Low
 
High
Modest

Odds Of Distress

Less than 10

 
100  
 
Zero
Low
Bio Rad is selling at 349.56 as of the 28th of March 2024; that is 2.65 percent increase since the beginning of the trading day. The stock's open price was 340.52. Bio Rad has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for Bio Rad Laboratories are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of February 2024 and ending today, the 28th of March 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
1st of January 1966
Category
Healthcare
Classification
Health Care
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California. The company has 23.42 M outstanding shares of which 503.41 K shares are currently shorted by investors with about 2.15 days to cover. More on Bio Rad Laboratories

Moving together with Bio Stock

  0.81EQ Equillium Financial Report 9th of May 2024 PairCorr
  0.64MDWD Mediwound Financial Report 4th of June 2024 PairCorr

Moving against Bio Stock

  0.69MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
  0.65KA Kineta Inc Report 29th of March 2024 PairCorr
  0.63MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.62VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.58MBIO Mustang Bio Report 3rd of April 2024 PairCorr

Bio Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Bio Rad's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bio Rad or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Bio Rad's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Bio Rad's managers, analysts, and investors.
Environment Score
Governance Score
Social Score
ChairmanNorman Schwartz
Thematic IdeaMeasuring and Control Equipment (View all Themes)
Old Names[Biotest Aktiengesellschaft, Biosearch S.A]
Business ConcentrationLife Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NYSE Composite, SP 500 Index, WSE WIG INDEX, Warsaw WIG80 Index, Measuring and Control Equipment, Health Care, Life Sciences Tools & Services, Medical Devices, Healthcare (View all Sectors)
Excise Tax ActivitiesAnimal TestingCatholic
Average Analyst Recommendation
Analysts covering Bio Rad report their recommendations after researching Bio Rad's financial statements, talking to executives and customers, or listening in on Bio Rad's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Bio-Rad Laboratories. The Bio consensus assessment is calculated by taking the average forecast from all of the analysts covering Bio Rad.
Financial Strength
Based on the measurements of operating efficiency obtained from Bio Rad's historical financial statements, Bio Rad Laboratories may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. Financial strength of Bio-Rad Laboratories is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.210.2172
Sufficiently Down
Slightly volatile
Gross Profit Margin0.630.5358
Fairly Up
Pretty Stable
Total Current Liabilities338.4 M522.8 M
Way Down
Slightly volatile
Non Current Liabilities Total3.2 BB
Sufficiently Up
Slightly volatile
Total Assets12.9 B12.3 B
Sufficiently Up
Slightly volatile
Total Current Assets3.2 BB
Sufficiently Up
Slightly volatile
Total Cash From Operating Activities393.7 M374.9 M
Sufficiently Up
Slightly volatile
Bio Rad's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Bio Rad's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Bio Rad's bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of Bio Rad's outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Bio Rad's financial leverage. It provides some insight into what part of Bio Rad's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Bio Rad's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Bio Rad deploys its capital and how much of that capital is borrowed.
Liquidity
Bio Rad cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 1.41 B in debt with debt to equity (D/E) ratio of 0.16, which may show that the company is not taking advantage of profits from borrowing. Bio-Rad Laboratories has a current ratio of 5.39, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Bio Rad until it has trouble settling it off, either with new capital or with free cash flow. So, Bio Rad's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bio-Rad Laboratories sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bio to invest in growth at high rates of return. When we think about Bio Rad's use of debt, we should always consider it together with cash and equity.

Depreciation

202.02 Million
Bio Rad Laboratories (BIO) is traded on New York Stock Exchange in USA. It is located in 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 and employs 8,030 people. Bio Rad is listed under Life Sciences Tools & Services category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a total capitalization of 9.93 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bio Rad's market, we take the total number of its shares issued and multiply it by Bio Rad's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bio-Rad Laboratories runs under Life Sciences Tools & Services sector within Health Care industry. The entity has 23.42 M outstanding shares of which 503.41 K shares are currently shorted by investors with about 2.15 days to cover. Bio Rad Laboratories has about 434.21 M in cash with 374.94 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 62.03.
Check Bio Rad Probability Of Bankruptcy
Ownership Allocation
Bio Rad holds a total of 23.42 Million outstanding shares. The majority of Bio Rad Laboratories outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Bio-Rad Laboratories to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Bio Rad. Please pay attention to any change in the institutional holdings of Bio Rad Laboratories as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Bio Ownership Details

Bio Stock Price Odds Analysis

Contingent on a normal probability distribution, the odds of Bio Rad jumping above the current price in 90 days from now is roughly 2.27%. The Bio Rad Laboratories probability density function shows the probability of Bio Rad stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the stock has a beta coefficient of 1.7162 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Bio Rad will likely underperform. Additionally, bio Rad Laboratories has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
  Odds Below 349.56HorizonTargetOdds Above 349.56
97.69%90 days
 349.56 
2.27%
Based on a normal probability distribution, the odds of Bio Rad to move above the current price in 90 days from now is roughly 2.27 (This Bio Rad Laboratories probability density function shows the probability of Bio Stock to fall within a particular range of prices over 90 days) .

Bio Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Bio Rad that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Bio Rad's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Bio Rad's value.
InstituionRecorded OnShares
Thompson, Siegel & Walmsley Llc2023-12-31
348.5 K
Massachusetts Financial Services Company2023-12-31
322.3 K
Goldman Sachs Group Inc2023-12-31
288.7 K
Hound Partners, Llc2023-12-31
261.7 K
Northern Trust Corp2023-12-31
252.4 K
Morgan Stanley - Brokerage Accounts2023-12-31
250.1 K
Westfield Capital Management Company, Lp2023-12-31
247.2 K
Parnassus Investments, Llc2023-12-31
237.8 K
Norges Bank2023-12-31
226.5 K
Vanguard Group Inc2023-12-31
2.4 M
Blackrock Inc2023-12-31
1.5 M
View Bio Rad Diagnostics

Bio Rad Historical Income Statement

Bio Rad Laboratories Income Statement is one of the three primary financial statements used for reporting Bio's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Bio-Rad Laboratories revenue and expense. Bio Rad Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Bio Rad's Non Operating Income Net Other is very stable compared to the past year. As of the 28th of March 2024, Non Recurring is likely to grow to about 353.2 M, while Selling General Administrative is likely to drop about 481.6 M. View More Fundamentals

Bio Stock Against Markets

Picking the right benchmark for Bio Rad stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Bio Rad stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Bio Rad is critical whether you are bullish or bearish towards Bio Rad Laboratories at a given time. Please also check how Bio Rad's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bio Rad without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Technical Analysis Now

   

Technical Analysis

Check basic technical indicators and analysis based on most latest market data
All  Next Launch Module

Bio Rad Corporate Directors

Bio Rad corporate directors refer to members of a Bio Rad board of directors. The board of directors generally takes responsibility for the Bio Rad's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Bio Rad's board members must vote for the resolution. The Bio Rad board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Jeffrey EdwardsIndependent DirectorProfile
Tania DeVilliersCorporate DirectorProfile
Arnold PinkstonIndependent DirectorProfile
Joel McCombDirectorProfile

How to buy Bio Stock?

Before investing in Bio Rad, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Bio Rad. To buy Bio Rad stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Bio Rad. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Bio Rad stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Bio Rad Laboratories stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Bio Rad Laboratories stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Bio Rad Laboratories, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Bio Stock please use our How to Invest in Bio Rad guide.

Already Invested in Bio Rad Laboratories?

The danger of trading Bio Rad Laboratories is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Bio Rad is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Bio Rad. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Bio-Rad Laboratories is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Bio-Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Rad Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Bio Stock analysis

When running Bio Rad's price analysis, check to measure Bio Rad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Rad is operating at the current time. Most of Bio Rad's value examination focuses on studying past and present price action to predict the probability of Bio Rad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Rad's price. Additionally, you may evaluate how the addition of Bio Rad to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Is Bio Rad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.56)
Earnings Share
(21.83)
Revenue Per Share
91.453
Quarterly Revenue Growth
(0.07)
Return On Assets
0.0177
The market value of Bio-Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.